Efficacy and Safety of Ribavirin with Sofosbuvir Plus Ledipasvir in Patients with Genotype 1 Hepatitis C: A Meta-Analysis

BACKGROUND: Sofosbuvir and ledipasvir with or without ribavirin (RBV) regimens (SLR vs. SL) have exhibited promising results for the treatment of patients with hepatitis C virus (HCV) genotype 1 infection. AIM: To comprehensively compare the efficacy and safety of the SL and SLR regimen for the trea...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Qiu-Feng, Zhang, Qiong-Fang, Zhang, Da-Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067290/
https://www.ncbi.nlm.nih.gov/pubmed/27619394
http://dx.doi.org/10.1007/s10620-016-4291-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067290/
https://www.ncbi.nlm.nih.gov/pubmed/27619394
http://dx.doi.org/10.1007/s10620-016-4291-2

Ejemplares similares